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ABSTRACT 
The inclusion of gaming disorder (GD) as an official diagnosis in the ICD-11 was a significant 
milestone for the field. However, the optimal measurement approaches for GD are currently unclear. 
This comprehensive systematic review aimed to identify and evaluate all available English-language 
GD tools and their corresponding evidence. A search of PsychINFO, PsychArticles, ScienceDirect, 
Scopus, Web of Science, and Google Scholar identified 32 tools employed in 320 studies (N=462,249 
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participants). The evaluation framework examined tools in relation to: (1) conceptual and practical 
considerations; (2) alignment with DSM-5 and ICD-11 criteria; (3) type and quantity of studies and 
samples; and (4) psychometric properties. The evaluation showed that GD instrumentation has 
proliferated, with 2.5 tools, on average, published annually since 2013. Coverage of DSM-5 and ICD-
11 criteria was inconsistent, especially for the criterion of continued use despite harm. Tools converge 
on the importance of screening for impaired control over gaming and functional impairment. Overall, 
no single tool was found to be clearly superior, but the AICA-Sgaming, GAS-7, IGDT-10, IGDS9-SF, 
and Lemmens IGD-9 scales had greater evidential support for their psychometric properties. The GD 
field would benefit from a standard international tool to identify gaming-related harms across the 
spectrum of maladaptive gaming behaviors. 
 
Keywords: Gaming disorder; Behavioral Addiction; Screening; Assessment; ICD-11; DSM-5 
 
1. Introduction 
Online gaming is a hundred-billion-dollar industry that continues to innovate and expand on a 
global scale (King & Gaming Industry Response Consortium, 2018). Individuals of all ages are 
motivated to play games recreationally for relaxation, challenge, and socialization (Yee, 2006). While 
there are benefits associated with gaming (Granic, Lobel, & Engels, 2014), unrestricted gaming may 
be highly absorbing and time-consuming, and may become addictive for vulnerable individuals 
(Brand et al., 2016; Higuchi et al., 2017; King et al., 2019; Sim et al., 2012). Over the last three 
decades, increasingly accumulated research and clinical evidence has supported recognizing the most 
severely maladaptive forms of gaming behavior as an addictive disorder (Baggio et al., 2016; Feng, 
Ramo, Chan, & Bourgeois, 2017; Khazaal et al., 2016; King & Delfabbro, 2019; Meng et al., 2015; 
Mihara & Higuchi, 2017; Müller et al., 2015; Rehbein & Baier, 2015; Rumpf et al., 2018; Scharkow, 
Festl, & Quandt, 2014; van Rooij et al., 2010; Yao et al., 2017). However, despite the recognition of 
gaming disorder (GD), there remains uncertainty regarding optimal approaches to screening and 
assessment. This uncertainty is due, in part, to the many available, similarly named but varied 
measurement tools for the condition. To help inform the next phase of research on this new disorder, 
wherein lies an opportunity for researchers to collaborate and adopt a more consistent approach, the 
aim of this review was to critically evaluate all available GD tools and their corresponding evidence. 
Following a provisional status for ‘internet gaming disorder’ (IGD) in the DSM-5 (American 
Psychiatric Association, 2013), gaming disorder was officially adopted at the World Health Assembly 
in May 2019 as a diagnosis in the eleventh edition of the International Classification of Diseases 
(ICD-11; WHO, 2019). GD is characterized by persistent gaming behavior, impaired control over 
gaming, and functional impairment due to gaming for a period of at least 12 months in most instances 
(Saunders et al., 2017). Individuals with GD play games to the exclusion of other activities, resulting 
in missed life opportunities and interference with normal routine and basic self-care (i.e., sleep, 
eating, personal hygiene); real-world social interaction (i.e., meeting friends, visiting family); and 
important responsibilities (i.e., school, work, care of children) (Allison, Von Wahlde, Shockley, & 
Gabbard, 2006; Beranuy, Carbonell, & Griffiths, 2013; Griffiths, 2010). Individuals with GD often 
feel unable to regulate or cease their gaming behavior, and experience intense negative mood states 
(e.g., irritability, sadness, and boredom) when unable to play (Dong, Wang, Du, & Potenza, 2017; 
Kaptsis, King, Delfabbro, & Gradisar, 2016). Personal distress may also relate to a fear of missing out 
on the online game world, where the user feels a strong sense of personal identity and self-efficacy 
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(King & Delfabbro, 2014; Lemenager et al., 2013; Marino & Spada, 2017; Wegmann, Oberst, Stodt, 
& Brand, 2017). With the official inclusion of GD as a diagnostic category in the ICD-11, it was 
considered timely to evaluate the extent to which current instruments were consistent with current 
defining elements of GD. 
Previous reviews and related articles on GD instrumentation have reported various 
inconsistencies and psychometric weaknesses (King et al., 2013; Griffiths, King, & Demetrovics, 
2014; Lortie & Guitton, 2013; Petry et al., 2014; Starcevic, 2013). The most recent major systematic 
review examined 18 assessment tools employed in 63 studies and reported problems including 
inconsistent cut-off scores and symptom coverage, and inadequate data on predictive validity and 
inter-rater reliability (King et al., 2013). Uncertainty has also arisen due to the common research 
practice of adapting or developing new tools rather than using previous ones. Prior to the provisional 
DSM-5 criteria for GD, researchers would often adapt the criteria of other disorders (e.g., pathological 
gambling in the DSM-IV-TR) (Fisher, 1994; Griffiths, 1998). Over time, this practice evolved into 
adapting these criteria in new ways (e.g., word edits or substitutions, new response categories) and 
combining other previous items, sometimes sourced from three or more different scales, with new 
items to create composite measures (e.g., Groves, Gentile, Tapscott, & Lynch, 2015; Jap, Tiatri, Jaya, 
& Suteja, 2013; Peng & Liu, 2010).  
Inconsistent and/or inadequate measurement of GD has major implications for the quality of its 
research base, as well as for the allocation of clinical and public health resources to address social 
problems arising from GD. Epidemiological studies that employ short screening tools are relied upon 
to inform policy decisions and therefore must provide a valid indication of the problem. 
Epidemiological research on problematic gaming and GD has often been criticized for its sampling 
approaches, such as recruiting gamers from online gaming forums or sampling a limited pool of 
students from local schools or universities (van Rooij et al., 2018). However, the psychometric 
properties of measurement tools in GD studies have received relatively less critical attention. In recent 
years, there has been an increase in population cohort studies of GD, as well as many large-scale 
studies (e.g., the Longitudinal Cohort Study on Substance Use Risk Factors [C-SURF] of young men 
in Switzerland) that have incorporated gaming-related questions. For example, Rehbein et al. (2015) 
conducted a state-representative school survey of 11,003 adolescents aged 13 to 18 years using the 
DSM-5 criteria for GD and reported a 1.2% prevalence of GD. A study by Müller et al. (2015) 
examined GD in seven European countries based on a representative sample of 12,938 adolescents 
between 14 and 17 years, reporting that 1.6% of the sample met the criteria for IGD, with a further 
5.1% at risk for GD by meeting up to four criteria. Other studies have reported comparable figures, 
including: 0.6% of 816 Norwegian adolescents (Mentzoni et al., 2011); between 0.3 and 1.0% in four 
international cohorts totalling 18,932 people (Przybylski et al., 2016); 2.0% in a sample of 1,718 
Chinese adolescents (Mak et al., 2014); 1.3% in a nationally representative panel of 902 Dutch 
gamers (Haagsma et al., 2012); 1.5% of Dutch adolescents (van Rooij et al., 2011); and 1.8% of 1,287 
Australian adolescents (King et al., 2013). These figures appear to be comparable with prevalence 
estimates reported for other similar conditions, such as gambling disorder (Calado & Griffiths, 2015). 
However, there have also been numerous studies of GD that have reported much higher prevalence 
figures, including rates in excess of 15-20% which seem to defy logic (Seok & DaCosta, 2012; Wang 
et al., 2014; Xin et al., 2018) and raise concerns about the validity of instrumentation and associated 
risks such as false positives. 
 
1.4. The present review 
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The present review aimed primarily to evaluate all available GD and related instruments and 
their associated empirical evidence base. Although numerous tools refer to IGD in their name and/or 
source publication, which is the construct used in the DSM-5, this review uses the abbreviation GD to 
encompass both the DSM-5 and ICD-11 classifications, including when referring to all tools and 
constituent items. A secondary aim of this review was to provide insights into the nature and quality 
of the overall evidence base on GD. This evaluation was guided by a similar previous major review 
conducted by King et al. (2013) prior to the inclusion of IGD as a condition for further study in the 
DSM-5. It was reasoned that the 2013 review should be updated given that new data may often inform 
a new consensus on a topic, particularly in a rapidly changing field. The Cochrane Collaboration, for 
example, recommends that systematic reviews are updated every two years (Moher et al., 2008).  
The 2013 systematic review was informed by standards in psychological assessment (Cicchetti, 
1994; Groth-Marnat, 2009), which were incorporated into the new framework for the present review. 
The 2013 review highlighted some of the conceptual inconsistencies across GD tools, as well as gaps 
in empirical evidence underlying available measures’ psychometric properties. In addition to 
describing the conceptual and practical considerations of all GD tools, the present review sought to 
address basic questions of: (1) whether current tools were consistent with the DSM-5 and ICD-11 
criteria; (2) which tools were being used in which specific research areas (i.e., epidemiological, 
neurobiological, interventions); and, (3) which tools had received relatively greater evidential support 
for their psychometric properties. 
 
2. Methods 
2.1. Identification and selection of tools 
This review aimed to identify and examine all available instruments for screening or assessing 
problematic gaming and/or GD. Tools were selected for inclusion if they met the following criteria: 
(1) peer-reviewed and published in English language; (2) accessibility of all test items and response 
categories (e.g., list in appendix section, or analysis of test items, e.g., factor analysis); (3) primarily 
designed to measure problematic gaming or gaming disorder, and not internet addiction or other 
condition (NB: an exception was made for widely used internet addiction tests that refer specifically 
to gaming activities, e.g., the Young Internet Addiction Test [YIAT; Young, 1998] and Compulsive 
Internet Use Scale [CIUS; Meerkerk, Van Den Eijnden, Vermulst, & Garretsen, 2009), and for the 
Screener for Substance and Behavioural Addictions  [SSBA; Schluter, Hodgins, Wolfe, & Wild, 
2018] as a behavioral addiction tool); (4) the test was self-report (i.e., not completed by an external 
rater, e.g., parent); and, (5) the test was original and not a composite of two or more existing measures 
and/or adapted DSM or other diagnostic criteria (e.g., alcohol-use disorder criteria adapted to 
gaming). A database search was conducted on 4 April 2019 by the first author (DLK). The Google 
Scholar and academic databases, including PsychINFO, PsychArticles, PubMed, ScienceDirect, 
Scopus, and Web of Science, were searched using the following keywords and protocol: ((measure or 
tool or test or validation or psychometric or screening or diagnostic or item or instrument) AND 
gaming). Figure 1 presents a PRISMA summary of the database search that yielded a total of 5,828 
results (including duplicate results). The titles and abstracts of all results generated by each database 
were screened for relevance using the above inclusion criteria, which led to the identification of 32 
tools, including tests with multiple item formats (see Table 1 for the complete list).  
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2.2. Identification of empirical literature underlying tools 
The second phase of the search protocol involved identifying all empirical studies that have 
employed at least one of the identified 32 tools. This search protocol involved a procedural 
examination of the Google Scholar citation records for all identified tools (as of April 2019). Google 
Scholar was used because it is rapidly updated to include new results across multiple academic 
databases. Table 3 provides a summary of the citation records for each tool; citation counts were 
highly variable and ranged between no citations and 5,413 citations. The total citation count for all 
tools combined was 12,996 (NB: papers citing a paper that presented multiple versions of a tool were 
counted only once). These records were examined to identify empirical studies published in English. 
There were no restrictions on inclusion of studies based on study type (e.g., intervention, 
epidemiological, neurobiological), publication date, or any potential methodological shortcomings. 
However, articles that were not peer-reviewed (e.g., dissertation material, conference proceedings) 
were excluded. Supplementary material 1 presents a numbered list of 328 references, with each 
number corresponding to the evidence cited in superscript format in Tables 5 and 6.  
  
2.3. Tools evaluation framework  
This review aimed to provide a comprehensive descriptive summary and critical evaluation of the 
conceptual and psychometric properties, and practical considerations, of all 32 identified tools. This 
evaluation was conducted in stages under the guidance and collaboration of members of the research 
team, which was composed of 14 experts (i.e., psychiatrists, research professors, psychometrician, 
clinical psychologists) in the field of GD and behavioral addictions. This review was informed by the 
structure and protocols of the previous systematic review of GD tools conducted by King et al. 
(2013). The 2013 review was based on 18 tools (N=63 studies) published up to 2012, and therefore 
preceded the DSM-5 and ICD-11 recognition of GD (NB: the DSM-5 has only recognized IGD as a 
provisional disorder, or condition in need of further study). The present review sought to address the 
question of whether available tools were consistent with, and capable of, assessing IGD/GD as 
described in the DSM-5 and ICD-11 classifications. The 2013 framework was guided by JARS 
reporting standards (APA Publications and Communications Board Working Group, 2008), as well as 
Cicchetti’s (1994) and Groth-Marnat’s (2009) criteria and guidelines for evaluating psychological 
tests.  
The present review aimed to incorporate the 2013 review’s framework components, as well as 
extend the previous review by including more advanced psychometric information. All tools and 
studies evaluated in this review (i.e., the master spreadsheets underlying all analyses in this review, 
which were created by DLK) were checked by at least 3 members of the research team (i.e., JB, NC, 
and PHD). Any discrepancies or errors in ratings or data entry were resolved by consultation among 
authors. At every stage of the review process, all members of the research team were provided with 
relevant updates and documentation outlining the procedures and results. All members were invited to 
contribute any feedback or other observations on this material. All feedback and suggestions were 
responded to as team messages for transparency. As explained in Section 2.3.4, there was a roundtable 
discussion attended in person by 14 team members at the 6
th
 International Conference on Behavioral 
Addictions in Yokohama, Japan, which enabled discussion of the review’s content (distributed 
electronically before the meeting) and reach consensus decisions on how to present this information in 
tabular format for a final report. 
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 2.3.1. Review framework I: Overview 
First, all 32 tools were summarized according to the following basic characteristics: (1) tool 
abbreviation (i.e., tool acronym or short-hand name; some tools were disambiguated by using new 
terms, e.g., ‘Petry IGD’ and ‘Lemmens IGD’ to minimise potential confusion with other scales with 
IGD as their namesake); (2) author and date (derived from original publication source); (3) tool 
components (i.e., constructs reportedly measured by the tool); (4) number of items (i.e., all tool items, 
including those which may not be included in scoring considerations (e.g., the AICA-Sgaming and C-
VAT2.0 include additional items for clinical judgement but are not scored); (5) response format (i.e., 
response options for tool items, e.g., yes/no); (6) cut-off score (i.e., cut-off for ‘problematic’ or 
‘addicted’ status on the test, based on original source reference, if reported); (7) age (i.e., participant 
with the lowest age who completed the tool in the original study); (8) country of origin (i.e., country 
of research team’s institution, with priority given to first author); and, (9) language versions (i.e., 
known language versions of the tool, based on the published evidence base only). 
 
2.3.2. Review framework II: DSM/ICD coverage 
The second step involved evaluation of each tool’s coverage of the DSM-5 and ICD-11 criteria 
for IGD/GD. Variation in coverage of criteria or guidelines is important because it may, for example, 
affect prevalence rates in epidemiological studies or affect diagnostic specificity in clinical practice. 
At the same time, it is acknowledged that total coverage of DSM/ICD criteria is not essential for the 
purpose of screening, where having fewer items is considered more feasible for the purpose of 
obtaining insights into, or estimates of, potential harms. Each test’s description of its components (i.e., 
symptoms) were compared to each of the criteria in their respective DSM-5 and ICD-11 categories. 
The DSM-5 criteria included 9 symptoms (see American Psychiatric Association, 2013); the ICD-11 
guidelines included 3 criteria (i.e., 1: impaired control, 2: increasing priority given to gaming; 3: 
continuation of gaming despite harm; see WHO, 2019) and then functional impairment which was 
delineated into 5 main areas (i.e., personal [psychological/physical well-being], social, education, 
work, and financial). The Table 2 legend provides further information on each type of impairment. 
The rationale for delineating impairment types was to identify tools that may provide contextually 
useful information on gaming-related consequences, such as greater applicability to certain 
investigations (e.g., studies of social correlates of gaming) or special populations (e.g., school-related 
consequences of excessive gaming).  
 
2.3.3. Review framework III: Quantifying the evidence base 
The third step of the evaluation involved a detailed summary of the empirical evidence base for 
all 32 tools. The evidence was summarized according to: (1) Google Scholar citation count (i.e., all 
citations, irrespective of publication type); (2) Number of empirical studies (i.e., studies that 
employed the tool, excluding any non-quantitative studies); (3) Validation studies (i.e., studies that 
involved tool validation based on nationally representative or clinical samples, delineating studies 
according to those conducted by: (i) the tool’s original author, and (ii) independent research teams); 
(4) Intervention studies (i.e., studies involving any type of intervention, e.g., psychotherapy, 
prevention); (5) Clinical sample (i.e., participants with diagnosed GD or probable GD using a 
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structured clinical interview by a psychiatrist, clinical psychologist, or qualified registrar; participants 
seeking treatment for GD; and both aforementioned scenarios); (6) Longitudinal studies (i.e., studies 
with repeated observations of the same sample, with no restriction on intervals between observations); 
(7) Prevalence studies (i.e., studies yielding a GD prevalence rate based on a nationally representative 
sample or subsample [e.g., adolescents] of the population), and; (8) Neurobiological studies (i.e., 
studies that employ imaging technologies, such as functional magnetic resonance imaging (fMRI), 
and/or neurocognitive measures. In addition, a descriptive summary of the samples’ size and age 
composition, and recruitment approaches, associated with each tool was generated. The review 
framework delineated: (1) Total N (i.e., the total number of participants who have been administered 
the tool across all studies); (2) Participant age (i.e., adolescent [<18 years] vs. adult age); and (3) 
recruitment strategy (i.e., convenience vs non-convenience sampling). This information was then used 
to calculate the relative proportion of age groups and convenience sampling for each tool. 
 
2.3.4. Review framework IV: Psychometric properties of tools 
The fourth step of the review summarized the research evidence on each test’s psychometric 
properties. The broad aim was to determine the nature, quantity, and overall consistency of research 
support for each tool’s validity and reliability. Applying the framework published by King et al. 
(2013), and extending this framework to consider new areas of test refinement and clinical utility, this 
undertaking considered the following areas for evaluation: (1) Dimensionality (i.e., type of statistical 
analysis, e.g., exploratory factor analysis; results, e.g., 1-factor solution); (2) Reliability (i.e., internal 
consistency, test-retest coefficients); (3) Refinement (i.e., results of Rasch analysis, item response 
theory [IRT], measurement invariance); (4) Validity (i.e., convergent, criterion); (5) Relationship to 
impairment (i.e., association with recognized measure of functional impairment); and, (6) Clinical use 
(i.e., known utility within a clinical interview; use as an outcome measure for a structured 
intervention).  
Information on each of the above psychometric areas was extracted by systematic review of each 
of the 328 articles for compilation into Excel spreadsheets. This process was assisted by the advanced 
search function in Acrobat Reader DC to identify relevant keywords. For example, the keyword 
‘factor’ was used to identify all factor analyses reported across the 328 studies. Identification and 
registration of many of these areas involved a simple transposition of a numerical value (e.g., 
Cronbach’s alpha, or a bivariate correlation from a table). For test areas that involved interpretation of 
statistical analysis (i.e., Rasch, IRT, measurement invariance), the lead author was assisted by an 
experienced senior psychometrician (NC) who confirmed or clarified the reported results and 
interpretation (e.g., consistency of reporting with statistical results, such as correct handling of root 
mean square of approximation [RMSEA] values). All values and interpretation were compiled into a 
master spreadsheet for review and consultation by co-authors. 
 
2.3.4. Synthesis of review findings 
Given the volume of information yielded for each tool, a final summary table was created to 
provide a parsimonious overview and comparison of the 32 tools. The primary purpose of this table 
was to provide readers with a quick reference guide for each tool, which may guide decision-making 
regarding the utility of each tool for particular uses. The framework for this table was developed by a 
roundtable discussion involving 11 authors (DLK, SC, JB, KM, MNP, HJR, JS, VS, ZD, MB and SH) 
Jo
urn
al 
Pr
e-p
roo
f
Journal Pre-proof
and subsequently discussed and approved by all authors. The Table 7 legend provides a complete 
explanation of the components and scoring information. The scoring rubric was generated for each 
area to summarize the quantity and/or consistency of research evidence, where applicable. For 
example, a score of 0 referred to the absence of research evidence; a score of 1 indicated that only 1 
study was available, and; a score of 2 indicated that 2 or more studies were available. For reliability 
indices, a study reporting a value of .70 or above was considered generally sufficient for inclusion 
(Cronbach, 1951; Lance, Butts, & Michels, 2006; Schmitt, 1996), acknowledging the caveats of this 
cut-off, e.g., that longer scales tend to have higher alphas (Cicchetti, 1994; Groth-Marnat, 2009). For 
criterion and convergent validity, an association of .3 or above was the cut-off (i.e., moderate; Cohen, 
1992). Scoring was not weighted and thus does not necessarily reflect the overall quality (i.e., 
validity, reliability, utility) of each tool. Some tools with relatively more highlighted areas may have 
other specific deficiencies that make them less suitable than other tools. Some tools with fewer 
highlighted areas may simply reflect that the tool is more recent and therefore has less supporting 
evidence.  
 
3. Results 
3.1. Overview of tools 
Table 1 presents a summary of all 32 tools, including original references and countries of origin, 
tool components, items, scoring information, and language versions. The tools have been presented in 
ascending order of publication date, with the non-gaming-specific tools (n=6) positioned separately at 
the end of the list. This order is used consistently for all tables except for Table 4, which is re-ordered 
to match the distribution of total N data in cells (i.e., descending frequencies) for ease of 
comprehension.  
Inspection of the list of tools and author information shows that some researchers (and/or their 
respective research teams) have created or contributed to the development of more than one tool. For 
example, Mark Griffiths (UK) is a named contributor on 5 tools (including 1 short version); Jeroen 
Lemmens (the Netherlands) is named on 5 tools (including 2 tools with extended versions); and Tony 
van Rooij (the Netherlands) is named on 2 tools. The most common country of origin was The 
Netherlands (n=7), followed by South Korea and Germany (n=4 each), and then the United States, 
United Kingdom, and Hungary (n=3 each). Most tools used continuous response categories, with the 
most common type being a 5-point scale (n=16). Only 9 tools employ “Yes/No” responses. Most tools 
(n=22) reported a cut-off score, and most tools (n=29) were reportedly suitable for respondents under 
the age of 18 years; however, the minimum age varied (n=15 specified 12-13 years of age). Most tools 
(n=29) were available in non-English languages. Overall, 29 different languages were represented. 
 
3.2. Coverage of DSM-5 and ICD-11 criteria 
Table 2 presents a summary of all tools’ coverage of the DSM-5 and ICD-11 criteria. This 
evaluation referred to the 9 criteria for DSM-5 IGD (i.e., preoccupation, withdrawal, tolerance, 
unsuccessful attempts to stop/limit, loss of interests due to gaming, continued use despite harm, 
deception, escape, and harm) and the 3 guidelines for ICD-11 GD (6C51) (i.e., impaired control, 
increasing priority to gaming, and continued use despite harm) and functional impairment (see 
Section 2.2). This evaluation showed that, overall, there was inconsistent symptom coverage across 
the 32 tools. With regard to the DSM-5 criteria, the most consistent criterion (n=31 tools; 97%) was 
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“9: Has jeopardised or lost a significant relationship, job, or educational or career opportunity due to 
gaming.” Other common criteria were symptoms 1 (preoccupation), 2 (withdrawal), 3 (unsuccessful 
attempts), and 8 (escape), with at least 27 tools including each symptom. Only 9 tools included 
symptom 6 (continued use despite harm). In total, only 8 tools provided coverage of all 9 DSM-5 
criteria (i.e., Petry IGD, IGDS9-SF, PIE-9, IGDT-10, CVAT2.0, IGUESS, and DIA).  
With regard to ICD-11 GD guidelines, all 32 tools including at least one item for “1: impaired 
control over gaming.” Most tools (n=28) measured “2: Increasing priority given to gaming to the 
extent that gaming takes precedence over other life interests and daily activities.” As noted for the 
DSM-5 criteria, only 9 tools included the ICD-11 criterion “3: Continuation or escalation of gaming 
despite the occurrence of negative consequences.” Coverage of specific types of functional 
impairment was inconsistent. Consistent with King et al.’s (2013) findings, the most common type of 
impairment referred to negative social consequences (n=30), followed by negative personal (n=20) 
and occupational (n=18) consequences. Only 5 tools referred to negative financial consequences of 
gaming (e.g., debt, overspending on game content; see Brooks & Clark, 2019; Zendle & Cairns, 2018, 
2019). In total, only 3 tools provided coverage of all 3 ICD-11 guidelines and 4 domains of functional 
impairment (i.e., Petry IGD, PIE-9, and IGDT-10), and an additional 4 tools covered all 3 ICD-11 
guidelines and 3 domains of functional impairment (i.e., IGDS9-SF, SCI-IGD, CVAT2.0, and DIA).  
Overall, there were 8 tools that provided total coverage of both the DSM-5 and ICD-11 criteria 
(i.e., Petry IGD, IGDS9-SF, PIE-9, IGDT-10, SCI-IGD, CVAT2.0, IGUESS, and DIA). Of this list, 
only 3 tools referred to 4 types of functional impairment (i.e., Petry IGD, PIE-9, and IGDT-10). 
 
3.3. The evidence base underlying GD tools 
Table 3 summarizes the empirical research literature (n=320 studies, excluding duplicates) that 
have employed at least one of the 32 GD tools (NB: Supplementary material 1 presents a list of 328 
references, which includes 8 duplicated references (i.e., refs 16-93, 19-95, 39-83, 48-177, 82-84, 88-
129, 195-212, 196-213; this duplication occurred during coding phases to disambiguate studies with 
more extensive information on multiple GD tools and/or study parts (i.e., Study 1, Study 2) to ensure 
that these data were cross-checked properly prior to entering into master spreadsheets.  
This evaluation provides an overview of a substantial proportion of the empirical GD literature 
(NB: it was beyond the scope of this review to estimate the overall size of the total empirical GD 
literature; i.e., including other studies that employ an unnamed or uncited instrument). Table 3 
indicates that the GD field has at least 30 longitudinal studies, 71 prevalence studies (i.e., studies that 
employ nationally representative samples), and 14 intervention studies. Overall, the most frequently 
used tools, irrespective of study type, were the YIAT (n=62), GAS-7 (n=45), and IGDS9-SF (n=24). 
The most common tool used in prevalence studies was the GAS-7 (n=18), which was also the most 
common tool for longitudinal studies (n=12). The YIAT has been used in 39 intervention studies and 
reports on treatment-seekers at baseline, with the majority (n=37) conducted in China and South 
Korea. 
The YIAT and YDQ are the most cited tools, which may be due to their prescience (i.e., these 
tools are presented in papers by the late Kimberly Young, a pioneer of the field of internet addiction; 
Brand & Potenza, 2019) and their earlier publication relative to other tools in the review. The Petry 
IGD tool is highly cited (n=447) relative to its use in studies (n=16), which may be due to being cited 
for its reference to international “consensus” on gaming disorder (i.e., many of its citations include 
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commentary and debate papers on the topic of consensus on DSM-5 IGD). Similarly, the A-EQ is 
highly cited (n=798) relative to its use in studies (n=22), which may be attributed to the paper’s wider 
discussion of the importance of distinguishing high (but non-problematic) engagement from addiction 
(Billieux, Flayelle; Rumpf, & Stein, 2019; Charlton & Danforth, 2007). Only two GD-specific tools 
(i.e., the AICA-Sgaming and VAT) have been used in both a national prevalence study and an 
intervention study. Overall, the YIAT, YDQ, and GAS-7 have been the most widely used and cited 
GD tools; however, none of these tools provide total coverage of the DSM-5 or ICD-11 criteria. 
 
 
3.4. Samples and recruitment strategies 
Table 4 presents a summary of the age composition of, and recruitment strategies for, samples in 
empirical studies of most GD tools (n=24). For this table, tools with only 1 study (n=8) were excluded 
due to insufficient cases to yield meaningful proportions. Overall, the total N for all identified studies 
was 462,249 participants, of whom 56% were aged 18 years or older. The GAS-7 has been 
administered to more participants (n=94,389) than any other tool, including the greatest number of 
participants recruited using non-convenience sampling (n=55,618). Studies employing the YIAT and 
YDQ also reported relatively high figures for total N (n=49,509 and n=30,916, respectively) and for 
participants recruited by non-convenience sampling (n=31,592 and n=29,810, respectively). The 
AICA-Sgaming was noteworthy for its relatively large evidence base (n=18, including 10 studies with 
clinical samples), fourth highest total N (36,306), and the highest percentage of non-convenience 
sampling (85.7%) among the overall most frequently used tools (i.e., ranked 4
th
 after the GAS-7, 
YIAT, and CIUS-14). Some tools (i.e., IGDS9-SF, GAS-21, and Petry IGD) have been administered 
to a relatively large number of participants, but these studies are predominantly based (i.e., >95% of 
total N) on convenience samples (e.g., online self-selected, non-representative samples). Only the 
IGUESS tool has total coverage of the DSM-5 and ICD-11 criteria along with an evidence base 
composed of samples obtained by non-convenience sampling; all other DSM/ICD-compatible tools 
are based on evidence with 95% convenience sampling.  
As a supplementary analysis, all sample figures were examined according to the DSM-5 criteria 
covered by the tools they had been administered in their respective studies (i.e., based on Table 2 
results). The objective of this analysis was to determine the extent to which study participants had 
been able to respond (e.g., affirmatively, negatively) to specific items referring to GD symptoms. The 
total N in each study corresponding to each tool was assigned to each of the relevant DSM-5 
symptoms covered by each tool. For example, the GAS-7 had been administered to 94,389 
participants, and therefore the value 94,389 was assigned to its measurement of symptoms of 
preoccupation, withdrawal, tolerance, etc. This process yielded an estimated total number of 
participants with the possibility of responding to any given GD symptom (e.g., assuming the item on 
the survey was completed).  
This evaluation showed that, overall, items referring to preoccupation, withdrawal, unsuccessful 
attempts, and harm had been administered to >96% of participants across the 320 studies. However, 
items measuring continued use despite harm (i.e., the DSM-5 and ICD-11 criterion) had been 
administered to only 11.9% of participants. Similarly, items measuring tolerance (67.6%), loss of 
interests (58.5%), and deception (48.3%) had been administered to relatively fewer participants across 
studies. When selecting only those studies with non-convenience samples, these figures were 
relatively similar across these symptoms (i.e., less than 4% difference), except for the item on 
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continued use despite harm, which reduced from 11.9% to 1.9%. Only 5053 participants out of the 
268,081 participants in non-convenience samples had been administered a tool with an item referring 
to continued use despite harm, indicating that this symptom was underrepresented in the literature.   
 
 
3.5. Psychometric properties of tools 
Table 5 presents the first of two summaries of the psychometric properties of the 32 tools based 
on their 320 empirical studies. The table summarizes the research evidence on test dimensionality, 
reliability, and test refinement. Most GD tools (n=27) have been examined using factor analytic 
techniques (or principal component analysis), but there are inconsistencies across tools in terms of 
factor analytic (FA) approach. Only 9 tools (i.e., POGU, POGQ, IGD-20, Petry IGD, Lemmens IGD-
9 and IGD-27, YDQ, and CIUS-214) have been examined by exploratory followed by confirmatory 
factor analysis (i.e., EFA and CFA conducted in independent subsamples) within the same study. The 
majority (n=21) of tools have been subjected to CFA only, with most studies providing the a priori 
reasoning that GD is a unidimensional construct. The majority of FA studies (n=47) reported that the 
GD construct is unidimensional (i.e., commonly referring to the GD construct composed of nine 
DSM-5 criteria, with the caveat that most tools actually assess fewer than 9 criteria; see Table 2). 
There was minimal empirical support for other dimensional structures (e.g., 2-factor solutions; n=3 
studies). Some tools demonstrated mixed and/or weak support for their factor structure (e.g., VAT, 
IGD-20, sIATgaming, YIAT-20, and CIUS-14). 
Internal consistency was generally high across the 31 tools (i.e., this was not reported for SCI-
IGD). With the exception of the BAM-VG, GAIA, VASC, CIUS-5, CIUS-8 and SSBA tools which 
had only 1 study reporting on internal consistency, each tool had at least two independent studies 
reporting Cronbach’s alpha values of at least 0.80. Considerably fewer tools (n=7; 9 studies) had 
examined test-retest reliability; in 8 of these 9 studies, the observed values from a 14-day or 30-day 
retest were satisfactory. The BAM-VG had a .73 test-retest reliability over a period of 90 days. There 
were 8 tools (i.e., GAS-7, POGQ, POG-SF, VAT, IGDS9-SF, IGDT-10, CIUS-14, CIUS-8) that had 
been evaluated by test-refinement analyses (e.g., IRT, Rasch analysis). Generally, these analyses 
provided support for the model fit and measurement invariance of each respective test. However, the 
IGDS9-SF reported mixed results for measurement invariance across cultural groups; it bears noting 
that these data were based largely (>95%) on convenience sampling, which may have affected 
analyses. 
 
 
Table 6 summarizes the research evidence on test validity, relationship to impairment, and 
clinical use of each tool. Convergent validity has often been operationalized in the GD literature as the 
bivariate association between gaming behavior (i.e., hours per week spent gaming) and total score on 
a GD tool. The research team discussed and agreed that habitual gaming for long periods (e.g., 6 to 8 
hours per day, or longer) was typical in the context of GD, and acknowledged that this behavioral 
pattern may fluctuate and that the condition was often episodic, but did not consider this association to 
be generally defining. Gaming may occur for some individuals as a regular and relatively frequent 
activity without reported associated major negative consequences, as described in previous studies 
(Király, Tóth, Urbán, Demetrovics, & Maraz, 2017; Triberti et al., 2018). King et al.’s (2013) review 
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reported the GD-gaming time association for convergent validity; therefore, it is reproduced with 
caution in this review. Overall, there were varied results on the association between gaming time and 
total GD tool score, with reported values largely ranging from .2 and .4 (i.e., small to moderate effect; 
Cohen, 1992). 
Criterion validity was evaluated by examining the association between scores on each GD tool 
and other similar or closely related tools (e.g., measures of gaming-related craving or maladaptive 
gaming-related cognitions). Most tools (n=28) have been examined in relation to other GD tools, 
particularly the YIAT (n=8 tool comparisons). The GAS-21, VAT, and the IGDS9-SF have reported 
the most consistently high correlations with other GD tools. Aside from the YIAT’s consistent 
convergent validity results across 11 studies, the IGDS9-SF was noteworthy for having 5 studies 
employing 4 different GD tools (i.e., GAS-7, IGD-20, Lemmens IGD-9, and YIAT) that reported 
associations exceeding r=.70. 
Only 6 tools (n=9 studies) have been examined in conjunction with standardized measures of 
functional impairment or quality of life. The PIE-9 was the only tool that has been evaluated using the 
recommended standard disability/impairment assessment (i.e., the World Health Organization-
Disability Assessment Schedule [WHO-DAS]). The IGD-20 has been examined in conjunction with 
the DSM global clinician rating scale (i.e., General Assessment of Functioning [GAF]). Other tools 
(i.e., the A-EQ, GAS-7, Lemmens IGD-9, and YIAT) have been evaluated using standardized quality-
of-life measures. 
Eleven tools have been employed in studies involving a clinical interview. Notably, the AICA-
Sgaming (n=11) and the YIAT (n=31) have been used most frequently. The AICA-Sgaming and Petry 
IGD are the two most commonly used gaming-specific tools within studies using clinical interviews. 
In relation to GD tools measuring treatment outcomes, only the YIAT (n=9 studies) and YDQ (n=2 
studies) have been used in more than one published study. Four other GD tools (i.e., the POGU, 
AICA-Sgaming, VAT, and IGD-20) have been employed in one study only. 
 
 
3.6 Quick reference guide to GD tools 
Table 7 presents a synthesis of the main areas of evaluation of the 32 tools. This table was 
designed to provide a ‘quick guide’ for researchers and clinicians, identifying tools with specific 
supporting evidence or use in particular study types. In this way, the table aims to provide a concise 
overview of the relative strengths and weaknesses for each tool, with the caveats that this table 
presents: (1) an unweighted representation of data underlying each of the criteria, meaning that the 
table does not differentiate between tools that meet certain score thresholds (e.g., 2 studies) and those 
that greatly exceed this basic threshold (e.g., not all tools that score 2 on ‘prevalence data’ should be 
considered equivalent); (2) total scores in the rightmost column should not necessarily be considered 
an overall indicator of tool quality (i.e., higher scores indicate the presence of research evidence in 
more areas, not higher tool quality); and, (3) higher scores in some areas may be undermined by 
weaknesses in other areas (e.g., tools with poorly sampled studies are less likely to be valid).  
Notwithstanding these limitations, the GD tools that fulfilled the most scoring criteria were the 
GAS-7, IGDS9-SF, IGDT-10, YDQ and Lemmens IGD-9. The GAS-7 is a much older gaming-
specific tool and precedes the DSM-5. Although the GAS-7 is still used frequently in research, 
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particularly in prevalence studies of European young people, this tool has not yet been used in 
intervention studies. Only the IGDS9-SF and IGDT-10 have DSM-5 and ICD-11 coverage, and only 
the YDQ has been used in a study involving clinical interviewing or an intervention. The IGDS9-SF 
and IGDT-10 had similar profiles in this evaluation, including basic length and scoring, and a 
comparably sized evidence base (i.e., in terms of total N) predominantly based on convenience 
samples. Overall, there was a mixed picture of the evidence on GD tools, with several tools with 
relatively higher evidential support in distinct areas (e.g., GAS-7, Lemmens IGD-9, AICA-Sgaming, 
and IGDT-10), but there was no markedly superior tool with distinct practical and/or psychometric 
advantages. 
 
4. Discussion 
The present review aimed to systematically evaluate all available instruments for GD. This work 
was intended to extend a previous major review of GD tools by King et al. (2013), which closely 
preceded the inclusion of GD as a condition for further study in the DSM-5. The 2013 review 
highlighted conceptual inconsistencies across GD tools, as well as gaps in empirical evidence 
underlying each measures’ psychometric properties. Seven years have passed since the preparation of 
King et al.’s (2013) report, and with the official inclusion of GD as a diagnostic category in the ICD-
11 in May 2019, it was considered timely to re-evaluate the state-of-the-art in GD screening and 
assessment. Overall, this evaluation has found that the GD field has greatly expanded in overall size 
and its array of GD-specific instrumentation, particularly since 2013, with at least 2 new tools, on 
average, published in each subsequent year. The field has also continued to employ several internet-
use-specific tools (e.g., the YIAT, created in 1998) to screen for gaming-related problems, particularly 
in East Asia. Overall, no single tool emerged from this evaluation as the clearly optimal choice. 
However, there were some relatively stronger tools (i.e., the AICA-Sgaming, GAS-7, IGDT-10, 
IGDS9-SF, and Lemmens IGD-9), identified on the basis of conceptual and/or practical 
considerations and greater volume of evidential support for their psychometric properties.  
The GD field is growing rapidly on a global level. This systematic review has identified 320 
empirical studies that have employed a combined total of 32 GD tools, with these studies conducted 
primarily throughout Europe and East Asia. However, there still appears to be some uncertainty or 
lack of agreement among GD researchers concerning optimal approaches to screening and 
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assessment, as indicated by the continuing creation of new tools that vary in scope and content. This 
review has identified inconsistencies in symptom coverage across 32 tools. Screening tools do not 
necessarily have to measure all criteria or guidelines for any given condition, including GD, in order 
to be effective. The objective is usually to capture the essential elements of behaviors in a brief 
format. This review shows that most GD tools tend to converge on the importance of screening for 
impaired control over gaming and gaming behavior that jeopardizes a significant relationship, or 
school or work opportunity. This means, however, that there are some criteria or guidelines for GD 
that tend to be excluded from tools. Notably, the criterion referring to continued use despite harm 
(which is included in the DSM-5 and ICD-11 criteria) has appeared in only 9 out of 32 tools. This 
review found that an estimated 88.1% of participants across 320 studies have not been administered a 
survey item that captures this particular symptom. The 8 tools that provide total coverage of both the 
DSM-5 and ICD-11 criteria (i.e., Petry IGD, IGDS9-SF, PIE-9, IGDT-10, SCI-IGD, CVAT2.0, 
IGUESS, and DIA) have been used in a combined total of only 5 nationally representative prevalence 
studies, or 7% of the prevalence study literature. These observations raise the issue of adequate 
representation of GD symptomatology in research, and whether these observed gaps in measurement 
should be factored into current estimates of incidence and prevalence.  
Sixteen GD-specific tools have been created since the recognition of IGD in the DSM-5 in 2013. 
However, many research teams have instead opted to use other tools that precede the DSM-5. 
Notably, the YIAT and YDQ measures have been used in numerous studies conducted within China 
and South Korea, particularly those involving clinical interviews to determine eligibility for 
neuroimaging evaluation and/or interventions. Similarly, research teams in Europe have often 
employed the GAS-7 for large-scale prevalence and cohort studies. The GD field therefore appears to 
be shaped by two main types of researchers: (1) those who continue to use older (i.e., pre-DSM-5) 
tools (i.e., the GAS-7, YIAT, and YDQ) despite the availability of new tools and guidelines for GD; 
and, (2) those who develop and attempt to validate their own tools which are often conceptually and 
practically similar, i.e., a tool of between 10 and 20 items that measures a unidimensional addiction 
construct derived from DSM-5 criteria. Further, regarding (2), the majority of new tools tend to be 
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psychometrically evaluated exclusively by the researchers who created them. The IGDT-10 and 
AICA-Sgaming are the only post-DSM-5 tools that have been employed in a study designed to 
validate psychometric properties by an independent research team. This suggests that there is an 
isolationist quality to the field’s collective efforts to study GD. Many teams appear to be operating in 
research silos rather than working collaboratively to develop a unified evidence base around a smaller, 
more manageable subset of measures. Reaching a consensus about the use of specific 
psychometrically validated screening tools in studies worldwide would not only optimize prevalence 
estimates, but may also be helpful for studies addressing psychological mechanisms underlying GD 
and for testing hypotheses on these processes as suggested in theoretical models (e.g., Brand et al., 
2019; Dong & Potenza, 2014; Wei et al., 2017). For comparison, the field of gambling disorder, 
which like GD is a disorder due to addictive behaviors recognized by the ICD-11 (albeit with a more 
extensive academic history than GD), has coalesced around 8 main tools used between 2000 and 
2015
1
 (see Calado & Griffiths, 2015).  
 
4.1 GD tools with greater evidential support 
This review identified five GD tools that have a relatively greater volume of evidential support 
for basic psychometric properties compared to other tools. These tools are the GAS-7, IGDS9-SF, 
IGDT-10, YDQ, and Lemmens IGD-9. However, no one tool appears clearly superior because many 
of the tools have similar strengths (e.g., the GAS-7 and Lemmens IGD-9 had a comparable evaluation 
profile), and each tool’s limitations were offset by other positive attributes. Some tools are untested in 
some contexts (e.g., treatment) or have not yet been evaluated psychometrically in some ways (e.g., 
item response theory). It may be anticipated that future research will address some of these gaps. On 
the other hand, given that research teams have tended to specialize in particular research areas (e.g., 
epidemiological, neuroimaging, treatment) and teams have often favored their own tools, some tools 
appear unlikely to be evaluated in certain types of research. The AICA-Sgaming, for example, has 
                                                                 
1
 These 8 tools are the South Oaks Gambling Screen (SOGS), Problem Gambling Severity Index (PGSI), DSM -
IV criteria for pathological gambling, Diagnostic Interview Schedule (DIS) for pathological gambling, 
Diagnostic Interview for Gambling Severity (DIGS), National Opinion Research Center DSM Screen for 
Gambling Problems (NODS), Gamblers Anonymous Twenty Questions (GA20), and the Lie/Bet scale.  
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been used in at least 10 studies of treatment-seekers, whereas 17 other tools have not been used in any 
research involving clinical samples. This situation may eventually lead to divergent streams of 
evidence for specific tools, such that some tools become the standard for some study types but not 
others, thereby complicating future tasks of synthesizing evidence across a broad literature. 
The GAS-7 was the most frequently positively rated tool (N.B., not to be conflated with 
psychometric superiority) due to its multiple positive features and large evidence base. Its research 
base included numerous datasets from prevalence studies throughout Europe, good criterion validity 
and reliability (internal, test-retest), and satisfactory performance on test refinement analyses (e.g., 
measurement invariance). However, the GAS-7 has not been used clinically, and therefore its utility 
as an outcome measure in treatment, or sensitivity to treatment-related changes, has not been 
investigated. In addition, the GAS-7 has incomplete coverage of DSM-5 and ICD-11 criteria, which 
may not be essential for screening purposes but remains noteworthy as the field turns its attention to 
locating measurement approaches consistent with ICD-11 classification. This may include research 
initiatives that involve developing new screening tools for behaviors that appear to have overlapping 
features with gaming (e.g., online social media use) by adapting items from existing GD tools
2
. 
Of the 5 tools with the broadest empirical support as identified in Table 7, the IGDS9-SF and 
IGDT-10 were the only tools that provided total coverage of the DSM-5 and ICD-11 criteria. The 
IGDS9-SF and IGDT-10 had similar profiles in this evaluation, including number of items and 
scoring approach, and a comparably sized evidence base (i.e., in terms of total N). Both tools were 
limited by their study samples; most studies (i.e., 23 out of 24) that employed the IGDS9-SF involved 
convenience samples, and the IGDT-10 has exclusively been used in convenience samples (i.e., all 7 
studies). The IGDT-10 is noteworthy, however, for its numerous language translations and use in 
relatively more countries, notably China and Japan (N.B., only 2 of the 32 tools have been translated 
into Japanese). Therefore, the IGDT-10 seems well positioned to bridge the research divide between 
Western and Eastern countries that is common in the GD literature. With regard to Eastern research, 
the YIAT and YDQ tools were most commonly used in Chinese studies (i.e., those published in 
                                                                 
2
 See recent papers on ‘scope creep’ (Haslam, 2016) and confirmatory bias in connection to the study of 
behavioral addictions (Billieux et al., 2015). 
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English), which stands in contrast to most research teams across Western countries that now rarely 
employ these two tools. 
 
4.2 Implications for debates on GD evidence  
The present review provides insights that should contribute to ongoing debate on the general 
quality and attributes of the GD literature. For example, some critics have asserted that the GD 
evidence base is flawed due to its reliance on convenience samples. A recent 37-author debate paper 
by van Rooij et al. (2018), entitled “A weak scientific basis for gaming disorder” argued against the 
inclusion of GD in ICD-11 on the basis that scientific standards had not been met. Among other issues 
raised, the authors argued that sampling approaches were inadequate because studies recruited 
“healthy high-school/college students or non-representative online samples recruited from Internet 
gaming forums” (p.3). The authors also referred to the example of a Singaporean dataset, published in 
2011 (Gentile, 2011) and subsequently used in multiple publications without cross-attribution of the 
data, to support their contention that the literature suffered from “poor methodological choices that 
undermine our confidence in the findings” (van Rooij et al., 2018, p.4). While it is necessary that 
authors cite specific examples for academic arguments, it is important that such examples do not form 
the basis for unwarranted generalizations that may then be misconstrued as scientific consensus. The 
present review’s findings did not support this particular criticism regarding sampling. Based on 320 
GD studies of which the majority report independent datasets, there was actually a slight majority of 
participants (N=268,081 or 58% of all participants) recruited using non-convenience sampling 
methods (e.g., nationally representative studies, stratified sampling by age, region, urbanicity, and 
treatment-seekers). It is inaccurate to conclude, therefore, that the GD evidence as a whole is 
fundamentally flawed or “weak” as a consequence of its recruitment strategies and sample sizes. 
Indeed, the present review may provide a useful resource for other matters of debate concerning the 
size and quality of GD evidence.  
 
4.3 Future research directions 
This review suggests some potential future research avenues to improve GD assessment. As 
recommended by King et al. (2013), there is a continued need for high-quality epidemiological and 
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intervention studies, including within these studies with a focus on sensitivity/specificity estimates. 
Studies of gaming behavior should include consistent measures of comorbidity (e.g., to address 
questions regarding the presence of other mental disorders, such as depression, anxiety, attention-
deficit/hyperactivity or other factors such as past trauma that may affect risk of GD). Similarly, future 
work should consider not only addictive aspects, but also other relevant perspectives and concepts 
related to understanding repetitive behaviors, notably impulsivity and compulsivity, in further 
developing and refining instruments and diagnostic criteria. Non-problematic gaming habits, as well 
as diagnostically subthreshold entities such as ‘hazardous gaming’ (QE22) in the ICD-11, deserve 
closer attention (Potenza, 2018). The focus of most studies of GD has been on the harmful 
consequences of gaming, without taking into account the potential benefits of gaming activities for 
some individuals. GD symptoms and negative consequences of gaming should be weighed against 
reported benefits of gaming, particularly at lower levels of problematic gaming (e.g., meeting between 
1 and 4 DSM-5 criteria). This may determine whether some individuals classified within ‘low risk’ 
categories might in fact report that gaming has a net benefit on their quality of life and psychological 
wellbeing or whether this sub-diagnostic level is associated with more mental health concerns, as is 
typically the case in gambling disorder (Desai & Potenza, 2018).  
Another avenue for future research is the use of player data in combination with GD tools and 
related measures. The field has often relied on self-report approaches to validate tools, which has 
unavoidable limitations (e.g., biased recall, denial/defensiveness, lack of insight). Conventional 
survey and interview approaches may be supplemented by player data to provide an objective 
historical account of gaming behavior; i.e., to describe or corroborate patterns of behavior that may 
otherwise be difficult to recall. Such data may be acquired by using an app-like or similar monitoring 
device or software. Considerations regarding how to work together with groups from the gaming 
industry warrant transparent discussion in order to help ensure scientific integrity in 
academic/industry collaborations (Griffiths & Pontes, 2019; King & Delfabbro, 2019). Another area 
for future research concerns the evolving technological nature of modern online video games, 
particularly the monetization of in-game content (e.g., in-game purchasing, microtransactions, and 
‘loot boxes’; see King et al., 2019; Zendle & Cairns, 2018). Problematic gaming that involves 
interactions with monetized content may be more financially involved and share features in common 
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with gambling disorder (e.g., spending more than one can afford, borrowing or stealing money) (King 
& Delfabbro, 2018; King et al., 2019). GD tools may need to reflect some of these structural elements 
in gaming activities, such as additional questions to examine different behaviors and consequences 
related to different types of games and modes of access (e.g., smartphones, virtual reality) (King, 
Koster, & Billieux, 2019). The measurement of more in-depth player and gaming information (e.g., 
game types) is beyond the scope of screening approaches, but is suited to a semi-structured diagnostic 
interview for GD (i.e., akin to the Structured Clinical Interview for DSM or Mini International 
Neuropsychiatric Interview), which could be developed and used internationally.  
 
4.4. Limitations of the review 
The present review has several limitations that should be acknowledged. First, this review was 
based on English-language studies only, which excluded a significant proportion (i.e., potentially, the 
majority) of the East Asian literature (i.e., studies in Chinese, Korean, and Japanese, in particular). 
This review also did not include data from studies published in German, Dutch, and French. Although 
researchers working in these countries often publish their work in English journals, the potential 
omission of relevant data is likely to have affected the evaluation of tools originating from these 
regions, e.g., the AICA-Sgaming, CSAS, GAS-7, and sIAT-gaming. Similarly, in some countries, 
there is a substantial grey literature (e.g., government-led health surveys that include standard GD 
questions), which was not included in this review. This review also did not include studies that 
employed “adapted” DSM-5 criteria, which would not have affected the main evaluation of tools, but 
should be taken into account when considering this review’s observations of the broader GD literature 
(e.g., total number of prevalence studies). The review framework aimed to be more comprehensive 
than any previous review but there were still some gaps. This review did not consider, for example, 
the sensitivity/specificity of tools, because: (1) this information was very rarely reported; and, (2) the 
external standard was not always clear in relevant studies. Other areas that were not evaluated were 
predictive and divergent validity, due to inconsistencies in reporting that made it difficult to extract 
these data. This review takes into consideration the current conceptualizations of GD and IGD, which 
may be revised as more evidence accumulates. Finally, the review framework itself was limited by the 
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fact that many of the criteria were inter-related and often affected by other considerations (e.g., 
sampling method, sample size). 
 
4.5 Conclusions 
The inclusion of GD in the ICD-11 was a significant milestone for the field. The GD diagnosis is 
likely to stimulate new research investigations on a global level, in important areas of epidemiology, 
neurobiology, treatment, prevention and public health. The present review aimed to inform the next 
era of research by providing a comprehensive evaluation of all available English-language GD tools, 
including a critical appraisal of their associated empirical evidence. The framework employed in this 
review may be useful for scale evaluation in other areas. Overall, this evidence was found to be 
mixed, with no clearly optimal tool among 32 tools used across Western and Eastern countries. While 
the research base has grown rapidly and largely improved its methodologies, the field is hindered by 
the overproduction of conceptually similar tools which have divided research efforts and created 
uncertainty among researchers. Despite the abundance of new instrumentation, some tools have 
relatively greater evidential support for their psychometric properties, including the GAS-7, IGDS9-
SF, IGDT-10, and Lemmens IGD-9. Given that most new tools were developed following the 
inclusion of the provisional DSM-5 criteria, it seems likely that researchers will again “rush to 
market” to develop new tools that purportedly measure the new ICD-11 GD classification. For the 
field to prosper and attain greater legitimacy in the field of addiction studies, a more unified approach 
to measurement is important. Isolated research that creates a multiplicity of tools generates an 
incohesive and less convincing evidence base. The development of a gold standard tool, following 
past examples of screening for use of addictive substances (e.g., Saunders et al., 1993; ASSIST; WHO 
ASSIST Working Group, 2002), would be invaluable for steering this nascent field toward achieving 
valid identification of gaming-related harms, and developing more effective intervention strategies for 
those in need. 
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Table 1 An overview of all  reviewed tools  (n=32) for problematic gaming and gaming disorder 
Tool Author 
Components  
(N: Name) Items 
Response 
format Cut-off Age 
Country of 
origin Languages 
PVP Scale 
Sa lguero & 
Moran 
(2002) 
7: Preoccupation; 
tolerance; loss of control; 
withdrawal; escape; 
deception; disregard  
9 Yes/No NR 13 Spain 
ENG; FR; 
NOR; SPA  
A-EQ 
Charl ton & 
Danforth 
(2007) 
2: Addiction; engagement 29 7-point Unclear - 
United 
Kingdom 
ENG; FR 
GAS-7 
Lemmens et 
a l . (2009) 
7: Sa l ience; tolerance; 
mood modification; 
relapse; withdrawal; 
7 5-point 4/71 12 Netherlands 
ENG; CH; 
DE; FA; FI; 
FR; NOR; 
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confl ict; problems TR   
GAS-21 
Lemmens et 
a l . (2009) 
7: Sa l ience; tolerance; 
mood modification; 
relapse; withdrawal; 
confl ict; problems 
21 5-point Unclear 12 Netherlands 
ENG; FR; 
NOR; SRB; 
TR 
POGU 
Kim & Kim 
(2010) 
5: Euphoria; health 
problem; conflict; failure 
of self-control; preference 
for onl ine relationship 
20 NR NR 10 South Korea ENG; KOR 
AICA-
Sgaming 
Wölfling et 
a l . (2010) 
8: Loss  of control; 
tolerance; withdrawal; 
continued use; loss of 
interests; emotion 
regulation; jeopardising; 
craving 
15 4-point 13.5 13 Germany 
CZ; ENG; 
DE; ISL; 
GRK; LTU; 
NL; POL; 
ROU; SPA 
POGQ 
Demetrovics 
et a l . (2012) 
6: Preoccupation; overuse; 
immersion; social isolation; 
interpersonal conflicts; 
withdrawal 
18 5-point 66/90 12 Hungary 
ENG; FA; 
FR; FIN; 
HUN; ITL; 
KOR; 
MAL; 
NOR; SLO; 
SPA  
VAT 
van Rooij et 
a l . (2012) 
5: Loss  of control; 
preoccupation; 
withdrawal; conflict; 
coping 
14 5-point NR 13 Netherlands 
ENG; NL; 
PT 
POGQ-SF 
Pápay et al. 
(2013) 
6: Preoccupation; overuse; 
immersion; social isolation; 
interpersonal conflicts; 
withdrawal 
12 5-point 32/60 12 Hungary 
CZ; ENG; 
FIN; FI; FR; 
HUN; ITL; 
KOR; 
MAL; 
NOR; SLO; 
SPA  
s IAT-
gaming 
Pawl ikowski 
et a l . (2013) 
2: Loss  of control/time 
management; 
craving/social problems 
12 5-point NR   9 Germany ENG; DE 
IGD-20 
Pontes  et al. 
(2014) 
6: Sa l ience; mood 
modification; tolerance; 
withdrawal; conflict; 
relapse 
20 5-point 71/100 16 
United 
Kingdom 
AR: ENG; 
KOR; PT; 
SPA;  
GAIA 
Wong & 
Hodgins 
(2014) 
6: Loss  of control and 
consequences; 
engagement; withdrawal 
(agi tated/mournful); 
coping; shame   
26 5-point NR 18 Canada ENG 
Petry IGD Petry et a l . 
9: Preoccupation; 
tolerance; withdrawal; 
9 Yes/No 5/9 10 United 
ENG; CH; 
DE; FR; 
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(2014) reduce/stop; loss of 
interests; continued use; 
deception; escape; conflict 
States ITL; JP; 
KOR; NL; 
PT; SPA; 
TR 
IGDS9–SF 
Pontes  & 
Gri ffi ths 
(2015) 
9: Preoccupation; 
tolerance; withdrawal; 
reduce/stop; loss of 
interests; continued use; 
deception; escape; conflict 
9 5-point 25/45 10 
United 
Kingdom 
AL; ENG; 
CH; FA; 
ITL; POL; 
PT; SI; TR;  
Lemmens 
IGD-9 
Lemmens et 
a l . (2015) 
9: Preoccupation; 
tolerance; withdrawal; 
pers istence; escape; 
problems; deception; 
displacement; conflict 
9 Yes/No 5/9 13 Netherlands 
AR; ENG; 
CRO; DE; 
NL; TR;  
Lemmens 
IGD-27 
Lemmens et 
a l . (2015) 
9: Preoccupation; 
tolerance; withdrawal; 
pers istence; escape; 
problems; deception; 
displacement; conflict 
27 
Yes/No 
4-point 
Unclear 13 Netherlands 
ENG; NL; 
TR 
GAIT  
Vadlin et a l. 
(2015) 
9: Preoccupation; 
tolerance; losing track of 
time; craving; withdrawal; 
relapse; chasing losses; 
loss of interests; conflict 
15 5-point Unclear 13 Sweden ENG; SE 
CSAS 
Rehbein et 
a l . (2015) 
9: Preoccupation; 
withdrawal; tolerance; 
unsuccessful; continued 
use; loss of interests; 
escape; deception; conflict 
18 4-point 5/9 13 Germany ENG; DE 
PIE-9 
Pearcy et al. 
(2016) 
9: Preoccupation; 
withdrawal; tolerance; 
unsuccessful attempts; 
loss of interests; continued 
use; deception; escape; 
harm 
9 5-point 5/9 16 Austra lia ENG 
BAM-VG 
Sanders & 
Wi l liams 
(2016) 
3: Impaired control; 
Problems; other issues 
19 Yes/No 3 18 Canada ENG; FR 
IGDT10 
Kirá ly et al. 
(2017) 
Preoccupation; 
withdrawal; tolerance; loss 
of control ; giving up 
activi ties; continuation; 
deception; escape; 
negative consequences 
10 3-point 5/9 14 Hungary 
CZ; ENG; 
CH; CRO; 
FA; FI; FR; 
HUN; JP; 
NOR; POL; 
SPA 
SCI-IGD 
Koo et a l . 
(2017) 
9: Preoccupation; 
withdrawal; tolerance; 
unsuccessful attempts; 
loss of interests; continued 
12 Yes/No 5/9 12 South Korea ENG; KOR 
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use; deception; escape; 
confl ict 
VASC 
Yılmaz et al. 
(2017) 
4: Sel f-control; 
reward/reinforcement; 
problems; involvement 
21 5-point 90/105   9 Turkey ENG; TR 
C-VAT2.0 
van Rooij et 
a l . (2017) 
9: Preoccupation; 
withdrawal; tolerance; 
unsuccessful attempts; 
loss of interests; continued 
use; lying; mood 
modification; problems 
11 Yes/No 5/9 13 Netherlands ENG; NL 
IGUESS 
Jo et a l . 
(2018) 
9: Preoccupation; 
withdrawal; tolerance; 
unsuccessful attempts; 
loss of interests; continued 
use; deception; coping; 
confl ict 
9 4-point 10/18 10 South Korea ENG; KOR 
DIA 
Ryu et a l . 
(2019) 
9: Sa l ience; withdrawal; 
tolerance; difficulty in 
regulating use; loss of 
interests; persistent use; 
deception; use to avoid 
feelings; interference 
10 Yes/No 5/10 13 South Korea ENG; KOR 
YIAT 
Young 
(1998) 
6: Sa l ience; excessive use; 
neglecting work; 
anticipation; lack of 
control ; neglecting social 
l i fe 
20 5-point 70/100 10 
United 
States 
ENG; CH; 
DE; FR; 
ITL; KOR; 
PT; TR 
YDQ 
Young 
(1998) 
7: Preoccupation; 
tolerance; loss of control; 
withdrawal; deception; 
escape; conflict 
8 Yes/No 5/8 13 
United 
States 
ENG; CH; 
DE; FR; 
KOR; ITL; 
LTU; PT; 
ROU; SPA; 
TR 
CIUS-14 
Meerkerk et 
a l . (2009) 
6: Loss  of control; 
preoccupation; 
withdrawal; conflict; 
coping; conflict  
14 5-point 28/70 14 Netherlands 
ENG; CH; 
DE; FIN; 
FR; NL  
CIUS-5 
Besser et al. 
(2017) 
3: Loss  of control; conflict; 
coping 
5 5-point 7/25 16 Germany 
ENG; CH; 
DE; FIN; 
FR NL;  
SSBA 
Schluter et 
a l . (2018) 
4: Overuse; loss of control; 
coping; continued use 
4 6-point NR 18 Canada ENG 
CIUS-8 
Gmel  et al. 
(2019) 
6: Loss  of control; 
preoccupation; 
withdrawal; conflict; 
8 5-point 13/40 15 Switzerland 
ENG; CH; 
DE; FIN; 
FR; NL; 
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coping; conflict 
NR: Not reported. (y); years. Age: Age, in years, of the youngest respondent to complete the test. 
1
Lemmens et al. specify a cut-off of 4 out of 7 items met. Items are met if respondent indicates at least 3 
(‘sometimes’) out of 5. 
NB: The first 26 tools measure gaming-related problems only and are presented in order of publication 
date. The remaining 6 tools are Internet-related or all -purpose measures; these tools are also presented 
in order of publication date. 
List of tools: A-EQ: Addiction-Engagement Questionnaire; AICA-Sgaming: Assessment of Internet and 
Computer Addiction Scale-Gaming; BAM-VG: Behavioral Addiction Measure for Video Gaming; CSAS: 
Video Game Dependency Scale; C-VAT 2.0: Clinical – Video Game Addiction Test 2.0; DIA: Diagnostic 
Interview for Internet Addiction; GAIT: Game Addiction Identification Test; GAIA: Game Addiction 
Inventory for Adults; GAS-7: Game Addiction Scale-7 items; GAS-21: Game Addiction Scale-21 items; IGD-
20: Internet Gaming Disorder-20 Test; IGDS9-SF: Internet Gaming Disorder Scale-9 Short Form; IGDT-10; 
Internet Gaming Disorder Test-10 items; IGUESS: Internet Game Use-Elicited Symptom Screen; Lemmens 
IGD-9: Internet Gaming Disorder Scale-9 items; Lemmens IGD-27: Internet Gaming Disorder Scale-27 
items; Petry IGD: Petry et al. (2014) consensus statement on IGD criteria; PIE-9: Personal Internet 
Gaming Disorder Evaluation-9 items; POGU: Problematic Online Game Use; POGQ: Problematic Online 
Gaming Questionnaire; POGQ-SF: Problematic Online Gaming Questionnaire-Short Form; PVP Scale: 
Problematic Video game Playing Scale; SCI -IGD: Structured Clinical Interview-Internet Gaming Disorder; 
sIATgaming: Short Internet Addiction Test-Gaming; VASC: Video Game Addiction Scale for Children; VAT: 
Video Game Addiction Test; CIUS: Compulsive Internet Use Scale [NB: CIUS-5, CIUS-8 and CIUS-14 are 
not the published names but have been adopted for this review to minimize confusion between these 
multiple versions. Actual test names: CIUS-14 is ‘CIUS’; CIUS-8 is ‘Short form of the CIUS’; CIUS-5 is the 
‘Short CIUS’. Each number accompanying CIUS in this review refers to the number of items in each 
version]; YIAT: Young Internet Addiction Test; YDQ: Young Diagnostic Questionnaire.  
Languages: AL: Albanian; AR: Arabic; ENG: English; CH: Chinese; CRO: Croatian; CZ: Czech; DE: German; 
FA: Farsi; FIN; Finnish; FR: French; HUN; Hungarian; ISL: Icelandic; ITL: Italian; FI: Finnish; GRK: Greek; JP: 
Japanese; KOR: Korean; LTU; Lithuanian; MAL: Malay; PT: Portuguese; NL: Dutch; NOR: Norwegian; POL; 
Polish; ROU: Romanian; SE: Sweden; SLO: Slovenian; SPA: Spanish; SRB: Serbian; TR: Turkey. 
 
Table 2 Coverage of DSM-5 and ICD-11 gaming disorder criteria across all  tools  (N=32) 
 
T
o
o
l 
D
SM
-5
 
  1
. P
re
o
cc
u
p
at
io
n
 
  2
. W
it
h
d
ra
w
al
 
  3
. T
o
le
ra
n
ce
 
  4
. U
n
su
cc
es
sf
u
l 
at
te
m
p
ts
 
  5
. L
o
ss
 o
f 
in
te
re
st
s 
  6
. C
o
n
ti
n
u
ed
 u
se
 
  7
. D
ec
ep
ti
o
n
 
  8
. E
sc
ap
e 
  9
. J
eo
p
ar
d
is
ed
 l
if
e 
  I
C
D
-1
1
 
  1
. I
m
p
ai
re
d
 c
o
n
tr
o
l 
  2
. I
n
cr
ea
si
n
g 
p
ri
o
ri
ty
 
  3
. C
o
n
ti
n
u
at
io
n
  
  I
m
p
ai
rm
en
t 
- 
P
er
so
n
al
 
  I
m
p
ai
rm
en
t 
- 
So
ci
al
 
  I
m
p
ai
rm
en
t 
- 
Ed
u
ca
ti
o
n
 
  I
m
p
ai
rm
en
t 
- 
W
o
rk
 
  I
m
p
ai
rm
en
t 
- 
Fi
n
an
ci
al
 
  T
O
TA
L:
 D
SM
-5
1
 
  T
O
TA
L:
 I
C
D
-1
1
2
 
PVP 
Scale 
                  7 3 
A-EQ                   5 3 
GAS-7                   7 3 
GAS-
21 
                  8 3 
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 Note:  assessed;  not assessed. NB: See Table 1 for ful l  test names. Underl ined va lues  represent ful l  coverage of 
respective cri teria .  
1Refers  to tota l  DSM-5 cri teria  covered by test (max. 9).  
2
Refers to total ICD-11 cri teria covered by test (max 4); NB: 1 point for any speci fic impairment i tems (l i s ted below).  
Impairment types :  
Personal: Sleep, appeti te, wel l -being due to excess ive use , bas ic hygiene, other health-related issues . 
Social: Relationship conflict/interference, neglect, includes relationships with partner, children, other family members, and 
friends . 
Education: Confl ict/interference/disruption, neglect, loss  of educational  [school/univers i ty/learning] opportunities , 
productivi ty, outcomes . 
Work: Confl ict/interference/disruption, neglect, loss of occupational [paid/volunteer work] opportunities , productivi ty, 
outcomes . 
Financial: Problems related to spending too much money on gaming activi ties . 
 
POGU                   3 3 
AICA-
Sgami
ng 
                  7 2 
POGQ                   5 3 
VAT                   5 3 
POGQ
-SF 
                  5 3 
sIAT-
gamin
g 
                  6 3 
IGD-
20 
                  8 3 
GAIA                   5 3 
Petry 
IGD 
                  9 4 
S9
–SF 
                  9 4 
Lemm
ens 
IGD-9 
                  8 3 
Lemm
ens 
IGD-
27 
                  8 3 
GAIT                    6 3 
CSAS                   7 3 
PIE-9                   9 4 
BAM-
VG 
                  7 3 
IGDT1
0 
                  9 4 
SCI-
IGD 
                  9 4 
VASC                   4 2 
C-
VAT2.
0 
                  9 4 
IGUES
S 
                  9 4 
DIA                   9 4 
YIAT                   6 3 
YDQ                   7 2 
CIUS-
14 
                  6 3 
CIUS-8                   4 3 
CIUS-5                   2 3 
SSBA                   2 1 
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Table 3 The empirical evidence base for reviewed tools  for problematic gaming and gaming disorder 
     Clinical 
sample 
   Neurobiological 
Instrument Citations Studies Validat‡ Interv.    
SDI 
   
T-
S 
SDI & 
T-S 
Long. Prev. Imaging Cognitive 
PVP Scale 494 22 - - - 2 - - 7 - 2 
A-EQ 798 17 - - - - - 1 2 - - 
GAS-7 665 45 6;6 - - - - 12 18 1 3 
GAS-21 665 16 - - - - - 2 1 - - 
POGU 144 2 - 1 - - 1 - - - - 
AICA-
Sgaming 
55 18 3;1 1 - 1 10 - 5 3 - 
POGQ 155 8 - - - - - - - - 2 
VAT 83 7 1;0 1 - - - - 3 1 - 
POGQ-SF 78 6 1;0 - - - - - 2 - 1 
sIAT-
gaming 
153 8 - - - - - - - - - 
IGD-20 150 8 - 1 - - 2 - - - - 
GAIA 15 1 - - - - - - - - - 
Petry IGD 445 13 - - 4 1 - - - 4 1 
IGDS9–SF 152 24 1;0 - 2 - - 2 3 - - 
Lemmens 
IGD-9 
186 16 1;0 - - - - 4 4 - - 
Lemmens 
IGD-27 
186 2 1;0 - - - - - 1 - - 
GAIT  15 4 - - - 1 - 1 3 - - 
CSAS 12 2 - - - - - - 2 - - 
PIE-9 10 3 - - - - - - - - - 
BAM-VG 13 2 - - - - - 1 - - - 
IGDT-10 68 7 1;1 - - - - - 1 - - 
SCI-IGD 14 1 1;0 - 1 - - - - - - 
VASC 7 1 - - - - - - - - - 
C-VAT2.0 40 1 1;0 - - - 1 - - - - 
IGUESS 6 4 2;0 - 2 - - - 1 - - 
DIA - 1 - - 1 - - - - - - 
YIAT 2,387 62 - 9 23 - 16 5 2 24 3 
YDQ 5,413 12 1;1 1 - - 4 2 7 - 2 
CIUS-14 580 12 4;2 - 1 - - - 7 - 1 
CIUS-8 - 1 1;0 - 1 - - - - - - 
CIUS-5 5 1 1;0 - - - - - 1 - - 
SSBA 2 1 - - - - - - 1 - - 
TOTAL 12996 328 26;11 14 35 5 34 30 71 33 15 
Interv: Intervention s tudies. Long: Longitudinal s tudies. Prev: Prevalence studies. SDI: 
Structured/semi-structured diagnostic interview. T-S: Treatment-seeking sample. ‡Validation 
samples, where the first value i s the number of studies using nationally representative or clinical 
samples, and the second va lue in the total number of independent studies (i .e., studies not 
conducted by test author). NB: 328 s tudies due to duplicated entries for papers with multiple tests 
and s tudies (study 1, s tudy 2, etc). 
Underlined: Most frequent in column.  
 
Table 4 Sample size and recruitment for studies using the reviewed tools (n=24*), ranked by total N  
Tool Studies Total N Adol. Adult Conv. Non-Conv. %Adol %Non-Conv. 
GAS-7 45 94,389 22,616 69,789 38,393 55,618 24.0 58.9 
YIAT 62 49,509 1973 47,536 16,347 31,592 4.0 63.8 
CIUS-14 12 46,235 11,763 26,340 22,334 23,901 25.4 51.7 
AICA-Sgaming 18 36,306 28,447 7,859 5,211 31,095 78.3 85.7 
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YDQ 12 30,916 29,810 1,106 1,106 29,810 96.4 96.4 
PVP Scale 22 26,260 7,626 18,634 6,527 19,066 29.0 74.5 
CSAS 2 26,171 26,717 0 0 26,171 100 100 
IGDS9–SF 24 25,503 8,894 14,609 22,432 1,071 34.9 4.2 
IGDT-10 7 21,702 8,883 12,819 21,702 0 40.9 0 
Lemmens IGD-9 16 19,865 10,197 9,668 12,910 6,955 51.3 35 
POGQ-SF 6 18,366 14,809 3,557 3,557 14,809 80.6 80.6 
VAT 7 13,478 13,198 0 1,826 11,372 97.9 84.3 
POGQ 8 9585 2,524 7,061 9,585 0 26.3 0 
A-EQ 17 8113 3,332 4,781 4,781 3,332 41.1 41.1 
GAS-21 16 5807 1,676 4,131 5,500 88 29.9 1.5 
IGD-20 8 5454 930 4,524 4,379 1,075 17.1 19.7 
Petry IGD 13 4728 861 3,867 4,542 186 18.2 3.9 
BAM-VG 2 4448 0 4,448 506 3,942 0 88.6 
IGUESS 4 3796 3,796 0 0 3,796 100 100 
GAIT  4 3745 3,745 0 0 3,745 100 100 
Lemmens IGD-
27 
2 2901 2,444 457 2,444 457 84.3 15.8 
sIATgaming 8 2625 0 2,625 2,625 0 0 0 
POGU 2 1505 1,442 63 1,505 0 95.8 0 
PIE-9 3 842 0 842 842 0 0 0 
TOTAL 320 462,249 205,683 244,716 189,054 268,081 44.5 58.0 
*Tools not l isted due to 1 s tudy only: SCI-IGD, VASC, C-VAT2.0, GAIA, DIA, CIUS-8, CIUS-5, SSBA. 
Adol .: N of participants aged <18 years. Adult: N of participants  aged 
18+ years . Conv.: Convenience sample N. Non-Conv.: Non-convenience 
sample N. Includes nationally representative s tudies , cohort s tudies , 
randomly selected samples, treatment-seeking populations. NB: Studies 
with undifferentiated samples of adolescents and adults are included in 
‘Tota l  N’ but not listed in other columns. Underlined , bold: Largest N in 
column. For % columns, the highest value with 10+ s tudies  i s  bolded 
and underl ined. 
 
Table 5 Psychometric properties of GD tools I: Dimensionality, reliability, and scale refinement 
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 Dimensionality   Reliability   Refinement  
Instrument Method Factor structure  IC‡ 
Test-
retest 
 
Rasch; IRT 
Measureme
nt invariance 
PVP Scale PCA
1,7,11, EFA7, 
CFA2 
1-factor1,2,7,11 
 
 .59
2, .6221, .662, 
.691,15, .7418,20, 
.759, .786,11, .8013, 
.8413 
- 
 
 - - 
A-EQ PCA & EFA
22, 
CFA28 
2-factor22,28 
 
 .69
32,33, .7528, .7730, 
.7937, .8623,38, .8727, 
.9124 
-  - - 
GAS-7 EFA
50,72,73 
CFA39,45,48,50,51,7
2
 
1-
factor39,48,50,51,71,7
2
 
 
 .66
53, .7267, .7968,71, 
.8050, .8139,55, .8343, 
.84
65,70
, .85
47,52
, 
.8639,57, .8842, .8948, 
.9057, .9364, .9464 
.82 (2 
weeks)82
; .83 (2 
weeks)48 
 
 Rasch: partial 
credit model: 
satisfactory
48
; 
IRT us ing 
GRM: all  items 
with high 
discrimination 
parameters, 
some items 
with high 
DIF51 
Sex, Age 
groups: 
Configural
4
5; Sex, 
Usage: 
Configural, 
Metric, 
Sca lar48; 
Language 
groups 
(French, 
German): 
Configural7
2 
GAS-21 CFA83,88,97 
 
1-factor, 7 
second-order 
factors : 
supported
83,97
, 
not supported (1-
factor only)
88
 
 .92
83,87,88, 
.9483,84,94,95,96, .9697 
.76 (30 
days)88; 
.84 (2 
weeks)
84
 
 
 - - 
POGU 
(Kim) 
EFA & CFA120, 
CFA121,123,125,126 
 
6-factor 120,121,123, 
125,126 
 
 .84
122, .91121,127, 
.92125, .93123,126 
-  - - 
AICA-
Sgaming 
PCA102,113 1-factor102,113  .70
117, .79112, 
.82107; .84114,119, 
.89102,113, .92109 
-  - - 
POGQ EFA & CFA
120, 
CFA121,123,125,126 
6-factor 120,121,123, 
125,126 
 
 .84
122, .91121,127, 
.92125, .93123,126 
 
-  - Onl ine vs  
Offl ine 
groups: 
Configural, 
Metric, 
Sca lar125 
 
VAT EFA
132,133, 
CFA128 
1-factor128, 3-
factor133, 
Inadequate 
 .81
133, .92132, 
.93128,134 
.76 (30 
days)132 
 - Sex, 
Ethnicity, 
Grade 
Jo
urn
al 
Pr
e-p
roo
f
Journal Pre-proof
model132  groups: 
Configural, 
Metric128 
POGQ-SF CFA
135
 6-factor
135
  .90
137
, .91
135
, 
.92140, .93136,139 
-  - Sex groups: 
Configural, 
Metric, 
Sca lar135 
sIATgamin
g 
PCA & CFA141, 
CFA143,145 
1-factor145; 2-
factor141,143 
 .70
142, .81147, 
.84144, .85(143,145), 
.88
148
, .90
141
, .91
146
 
-  - - 
IGD-20 EFA & CFA
151, 
CFA149,152,155 
1-factor151; 6-
factor149,152,155 
 
 .85
155, .87152,156, 
.88149, .92150,151,154 
-  - - 
GAIA EFA157 6-factor157  .94157 -  - - 
Petry IGD EFA & 
CFA164,170 
1-factor164,170 
 
 .69
160, .70170, 
.72
162
, .77
166
, 
.78162,169, .82164, 
.86
163
 
-  - - 
IGDS9-SF EFA & 
CFA171,190 
CFA173,179,182-
189, 194 
1-factor171,179,182-
189,190,194 
 .81
185, .82173,187, 
.84185,193, 
.87181,185,186,191, 
.88171,172,180,183,184,19
2, .89184,190, 
.90
172,174,183,188,189
, 
.91182,183,184, 
.92174,175,176, .93179, 
.96178,185,194 
.87 (2 
weeks)18
9 
 2PLM IRT 
findings: High 
discrimination 
parameters 
for a l l 
i tems
182
; 
Items 6,7,8 
have poor 
fi t187, Rasch: 
partial credit 
model: Item 4 
had high 
DIF189 
Aust, US, 
UK: Mixed 
support183; 
US, India, 
UK; Mixed 
support
184
; 
Albania, 
US, UK, 
Ita ly: 
Mixed 
support185; 
Limited 
support186; 
Gender, 
Gaming 
time: 
Mixed 
support189; 
Gender, 
Age: 
Configural, 
Metric, 
Sca lar194 
Lemmens 
IGD-9 
EFA & CFA196, 
CFA195,198 
1-factor195,196,198  .67
210, .73208, 
.74201,206, .76208, 
.77201,206, .82197,200, 
.83
195,197
, .85
202
, 
.86198, .93196,205, 
.95199 
-  - - 
Jo
urn
al 
Pr
e-p
roo
f
Journal Pre-proof
Lemmens 
IGD -27 
EFA & CFA196, 
CFA195 
1-factor196; 1-
factor, 9 second-
order factors195 
 .95196, .94195 -  - - 
GAIT EFA
217
 1-factor
217
 
 
 .89
214
, .90
214
, 
.91215,216  
-  - - 
CSAS - -  .92219, .94218 
 
-  - - 
PIE-9 EFA, CFA220 1-factor220  .86220, .89220 .77 (2 
weeks)22
0
 
 - - 
BAM-VG PCA223 2-factor223  .87223 .73 (90 
days)223 
 - - 
IGDT-10 EFA
227
, 
CFA225,228,230 
1-
factor225,227,228,230 
 .62
230
, .68
225
, 
.73229, .75230, 
.76
227
, .85
226
, .87
228
 
-  2PL-IRT: 
Acceptable225 
Language, 
Gender 
groups: 
Configural, 
Sca lar 
invariance2
30 
SCI-IGD - -  - .41 to 
.91 (4 
weeks)23
2 
 - - 
VASC EFA, CFA233 4-factor233  .89233 -  - - 
IGUESS - -  .85236, .86238, .94235 -  - - 
DIA - -  .72239 -  - - 
YIAT-20 PCA297, CFA279 1-factor: poor 
fi t279; 3-factor, 4-
factor
297
 
 .86
263, .88284, 
.89282,301, .90269,299, 
.93
289
, 
.94242,283,298,299, 
.96266,285,294, .97263 
-  - - 
YDQ EFA & CFA311 1-factor311  .62 & .66 (KD-
20)311, 67303, .70313, 
.76306, .81306, 
.83
310
, .86
306
, .95
312
 
-  - - 
CIUS-14 EFA
318, EFA & 
CFA315,317CFA 
314,316,323 
1-factor with 
poor 
fi t314,315,317,323, 1-
factor316,318 
 .83
315, .86315, 
.87315, .89(314), 
.91317,319, .93323, 
.95318 
-  - Sex, Age, 
Education, 
Internet 
use 
groups: 
Configural
3
16 
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CIUS-8 CFA326 1-factor326  .89326 -  IRT-graduated 
response 
model: High 
discrimination 
parameters
326
 
Sex, 
Region, 
Age 
groups: 
Configural, 
Metric, 
Sca lar for 
Region and 
Age (not 
Sex)326 
CIUS-5 - -  .77327 -  - - 
SSBA PCA328 1-factor328  .87 -.95328 -  - - 
Superscript numbers refer to references; see Supplementary file 1 for complete reference list. C-VAT2.0 excluded due to lack of relevant 
results. 
‡Cronbach’s alpha value. Aust; Australia. CFA: Confirmatory factor analysis. EFA: Exploratory factor analysis. IC: Internal consistency. KD-
20: Kuder-Robinson; 
 PCA: Principal components analysis. IRT: Item response theory. UK: United Kingdom. US: United States.  
 
Table 6 Psychometric properties of GD tools II: Criterion validity, impairment, and clinical use 
 Convergent validity 
Criterion 
validity 
 
Impairment/QO
L 
 Clinical 
use 
 
Instrument Gaming behavior 
Other GD 
tests 
 Type: result 
 Independent 
evaluation 
Treatment changes 
PVP Scale .22
21, .238, .2421, 
.2816,18, .307,19, 
.482,9, .5414, .616, 
.6311, .641,15 
SOD: 
.471, .522, 
YDQ: 
.2712, 
YIAT: 
.32
15
, 
.5316, 
GAS-21: 
.7016, 
.7419, 
PIE-9: 
.43220 
 -  Psychiatric 
interview 
including K-
CIDI & PVP4 
- 
A-EQ .2028, .2133, .2930 Petry 
IGD: .56
28
 
 WHOQOL-
BREF: Al l  4 
sca les sign. 
lower for IGD: 
small to 
medium 
effect35, large 
effect
23
 
 - - 
GAS-7 .22
50, .3946, .4050, 
.4373,75, .4744,82, 
.4873, .5175, .5539, 
IGDS9-
SF: 
.4048,177, 
 PedsQL: - .15 
(SEM, B)48; 
HBSC: Mixed 
 - - 
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.5839, .6757, .6857 s IAT: 
.5153, 
GAIT: 
.83217, 
YDQ: 
.2777, 
YIAT: 
.4746, 
.6264, 
VAT: 
.74128, 
Petry 
IGD: 
.76
164
, 
PIE-9: 
.57
220
 
results52 
GAS-21 .19
97, .3293, 
.4294,95, .4584, 
.5583, .5883 
Onl ine 
Cognition 
Sca le: 
.73
87
, 
PVP: 
.70
94
, 
.7495, 
VAT: 
.8888, 
YIAT: 
.4588, 
.6397 
 -  - - 
POGU 
(Kim) 
- Craving: 
.48100 
 
 -  - Reduced POGU in CBI vs  
Controls100 
AICA-
Sgaming 
Addict>Control 
104,106,109,113,116
 
Craving: 
Addict> 
Control 10
4 
   Psychological 
consultation, 
including 
diagnostic 
interview and 
sca les101-
106,109,110, 
115,116,119 
Sign. post-treatment reduction 
in AICA-Sgaming score (large 
effect s ize)118 
POGQ .40
121, .45125, 
.46123,126 
PIUQ-6: 
.68121, 
IGDT-10: 
.69230, 
.77225 
 -  - - 
VAT Addict>Control
131
, .25128, .37128, 
.40
132
 
GAS-7: 
.74128, 
.88129, 
CIUS-14: 
.61128 
 -  - School-based prevention: 
Decreased VAT & screen time13 
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POGQ-SF .35139 PIU-6: 
.59139 
 -  - - 
sIATgamin
g 
.51146 -  -  - - 
IGD-20 .27
155, .42152, 
.49151, .58154, 
.77149 
DSM-5 
IGD 
cri teria: 
.82149, 
IGADS: 
.80
155
, 
IGDS9-
SF: .82171, 
KIAS: 
.59155, 
PIE-9: 
.64220, 
BAM-VG: 
.44223 
 GAF: 'Serious' 
for IGD 
group156 
 
 Psychological 
consultation 
and 
sca les153,156 
Reduced IGD-20 for PIPACTIC 
group156 
GAIA 
- YIAT: 
.80157, 
SSBA: 
.79328 
 -  - - 
Petry IGD .24
170, .33163, 
.38
166
, .42
164
, 
.59169 
A-EQ: 
.56
28
, 
CIUS-14: 
.59160, 
GAS-7: 
.76164, 
IGCS: 
.51169 
 -  Psychiatric 
interview 
including MINI 
and other 
sca les159,161, 165, 
168 
- 
IGDS9-SF .32
192, .33188, 
.34171, .36186, 
.44192, .47179, 
.52179, .55190 
GAS-7: 
.4048,177, 
.81194, 
IGD-20: 
.82171, 
Lemmens 
IGD-
9:.77190, 
TIAS: 
.57173, 
YIAT: 
.82178, 
.83194 
 -  - - 
Lemmens 
IGD-9 
.22210, .23195, 
.24
202
, .29
204
, 
.33199, .54204, 
.56
196
, .66
208
 
Parent 
vers ion 
of IGDS: 
.78198, 
IGDS9-
SF: .77190, 
YDQ: 
 KIDSCREEN-10: 
-0.42
200
, IGD vs  
non-IGD: 
PROMIS Global 
Health Scale: 
Small effect 
s ize, Neuro-
 - - 
Jo
urn
al 
Pr
e-p
roo
f
Journal Pre-proof
.39196 QOL Sleep 
Dis turbances: 
Small effect 
s ize211 
Lemmens 
IGD-27 
.23195, .56196 -  -  - - 
GAIT .48217 GAS-7: 
.83217 
 -  - - 
PIE-9  GAS-7: 
.57220, 
IGD-20: 
.64220, 
PVP: 
.43220 
 IGD vs  non-
IGD: WHO-
DAS: Large 
effect s ize220 
   
BAM-VG - IGD-20: 
.44223 
 -  - - 
IGDT-10 .03 (non-sig)
227, 
.30230, .45228 
PIUQ-6: 
.53231, 
POGQ: 
.69230, 
.77
225
 
 -  - - 
SCI-IGD - IGD > 
non-IGD 
group: K-
Sca le232 
 -  Psychiatric 
interview and 
sca les232 
- 
C-VAT 2.0 - -  -  Treatment 
professional 
consultation234 
- 
IGUESS IGD > non-IGD236 YIAT: 
.90
235
, K-
Sca le235 
 -  Psychiatric 
interview and 
sca les, with 
bl inded 
scoring of 
tests235,236 
- 
DIA - K-Sca le: 
.42
239
, 
YIAT: 
.39
239
 
 -  Tra ined 
cl inicians 
under 
psychologist 
supervision239 
 
YIAT .10
289, .21284, 
.31298, .51299, 
.57285, .58283 
GAS-7: 
.4746, 
.62
64
, 
GAS-27: 
.45
88
, 
.6397, 
PVP: 
.2712, 
 IGD vs  non-IGD 
group: 
WHOQOL-
BREF: Sign 
di ff
253
 
 Psychiatric 
consultation, 
including 
s tructured 
interview with 
sca les240,243-
246,248, 251-255, 
257-260,265, 267-
Non-s ig results240, Reduced YIAT 
scores for groups: 
Drug<Placebo/Control
251,252,253,29
1, Drug+CBT<CBT257, 2xDrug vs  
Control
258
, Single drug group
292
, 
CBT=VRT293 
Jo
urn
al 
Pr
e-p
roo
f
Journal Pre-proof
GAIA: 
.80157, 
IGDS9-
SF:.82178, 
.83
194
, 
IGUESS: 
.90
235
, 
DIA: 
.39239, 
CIUS-14: 
.62315 
269,273,276,277,280, 
287,288, 
290,291,293,294, 
Unspecified 
consultation
249
, 261,263,292 
YDQ IGD > non-IGD
307, 
.34
311
 
PVP: 
.27
12
, 
Lemmens 
IGD-9: 
.39196 
 -  Psychiatric 
consultation, 
including 
s tructured 
interview with 
sca les307,313, 
Unspecified 
psychiatric 
consultation304 
Reduced YDQ for treatment 
group (no control)
305
, Reduced 
YDQ in two treatment groups313 
CIUS-14 IGD > non-
IGD320,324, .28315, 
.33314, .35315, 
.42314, .47315 
VAT: 
.61128, 
YIAT: 
.62315, 
.66315, 
75315, 
Petry 
IGD: 
.59160 
 -  - - 
CIUS-5 - -  -  Structured 
cl inical 
interview for 
selected 
sample
327
 
- 
SSBA - GAIA: 
.79328 
 -  - - 
Superscript numbers refer to references; see Supplementary file 1 for complete reference list.  CSAS, CIUS-8, and VASC excluded due to 
lack of relevant results.  
CBI: Craving Behavior Intervention. CBT: Cognitive Behavior Therapy. GAF: Global Assessment of 
Functioning. Gaming behavior: Hours per week spent playing games. HBSC: Health Behavior in 
School-Aged Children Symptom Checklist; IGADS: Internet Game Addiction  Diagnostic Scale 
(Korean); IGCS: Internet Gaming Cognition Scale. K-CIDI: Korean version of the Composite 
International Diagnostic Interview. KIAS: Korean Internet Addiction Scale. SOD: Severity of 
Dependence Test. PedsQL: Pediatric Quality of Life Inventory Short Form. PIPACTIC: Individualized 
Psychotherapeutic Program for the Addiction to Information and Communication Technologies. 
PIUQ-6: Problematic Internet Use Questionnaire-6 items. SEM: Structural Equation Modeling. 
TIAS: Turkish Internet Addiction Scale. VRT: Virtual Reality Therapy. WHODAS: World Health 
Organization Disability Assessment Schedule. WHOQOL-BREF: World Health Organization Quality 
of Life - Brief Instrument. 
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Table 7 Quick reference guide to all  reviewed tools (n=32) for problematic gaming and gaming disorder 
 
To
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  9
. T
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  1
0
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n
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  1
1
. T
es
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re
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en
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  1
2
. I
m
p
ai
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en
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  1
3
. S
tr
u
ct
u
re
d
 i
n
te
rv
ie
w
  
  T
O
TA
L 
SC
O
R
E 
(/
2
3
) 
PVP 
Scale 
             6 
A-EQ              6 
GAS-7              17 
GAS-21              11 
POGU              3 
AICA-
Sgamin
g 
             9 
POGQ              6 
VAT              8 
POGQ-
SF 
             7 
sIAT-
gaming 
             4 
IGD-20              7 
GAIA              2 
Petry 
IGD 
             9 
S9–
SF 
             16 
Lemme
ns IGD-
9 
             11 
Lemme
ns IGD-
27 
             7 
GA T               9 
CSAS              7 
PIE-9              10 
BAM-
VG 
             4 
IGDT10              13 
SCI-IGD              5 
VASC              3 
C-
VAT2.0 
             5 
IGUESS              10 
DIA              6 
YIAT              9 
YDQ              12 
CIUS-14              12 
CIUS-8              7 
CIUS-5              4 
SSBA              4 
 
Ful l score is 2 points, except for the criteria 1, 2 and 3, where full score i s 1 point.  Full score.  Hal f-score.  No score. 
Underl ined va lues  denote the tests  with the highest scores . See Table 1 for ful l  test names.  
Scoring cri teria : 
Criterion 1: Coverage of DSM-5 Internet gaming disorder cri teria [0: Does not provide coverage of all DSM-5 IGD cri teria. 1: 
Coverage of a ll DSM-5 IGD criteria.]; Criterion 2: Coverage of ICD-11 Gaming disorder cri teria [0: Does not provide coverage 
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of a l l ICD-11 cri teria. 1: Coverage of all ICD-11 GD cri teria.]; Criterion 3: Cut-off score i s  present [0: No cut-off or unclear 
cut-off score. 1: Has  a  cut-off score.]; Criterion 4: Va l idation sample qual i ty, indicated by psychometric properties  
eva luated in a  nationally representative or clinical sample [0: No available data; 1: At least one s tudy; 2: at least 1 s tudy, 
and another study undertaken by an independent team]; Criterion 5: Prevalence data available [0: No available data. 1: Has 
1 nationally representative prevalence study. 2: Has 2+ nationally representative studies .]; Criterion 6: Longitudinal  data  
ava ilable [0: No available data. 1: Has 1 longitudinal s tudy. 2: Has  2+ longitudinal  s tudies .]; Criterion 7: Dimens ional i ty 
assessed by exploratory factor analysis and confirmatory factor analysis in two independent samples [0: No available data. 
1: 1 s tudy. 2: 2+ s tudies]; Criterion 8: Internal consistency, as assessed by Cronbach’s alpha [0: No available data. 1: 1 s tudy 
reporting alpha > .70. 2: 2+ s tudies reporting alpha > .70]; Criterion 9: Test-retest reliability [0: No available data. 1: 1 s tudy 
with a lpha > .70. 2: 2+ s tudies with alpha > .70]; Criterion 10: Cri terion va l idi ty, as  assessed by association with other 
GD/IGD tests [0: No avai lable data. 1: 1 s tudy reporting association reporting .3 or higher. 2: 2+ s tudies  reporting 
association .3 or higher.]; Criterion 11: Rasch or Item Response Theory [0: No available data. 1: At least 1 s tudy that reports 
s trong support for items/model fit using Rasch or IRT analysis. 2: At least 1 s tudy that gives s trong support for items/model  
fi t us ing Rasch or IRT analysis, and 1 s tudy undertaken by independent research team.]; Criterion 12: Test i s  s igni ficantly 
related to va lidated measure of functional impairment [0: No available data. 1: 1 s tudy with correlation of at least .3. 2: 2+ 
s tudies with correlation of at least .3]; Criterion 13: Test used in conjunction with s tructured/semi -s tructured interview 
involving a sample of treatment-seeking gamers or problem gamers with evidenced functional impairment [0: No available 
data. 1: 1 s tudy; 2+ s tudies .] 
 
Figure 1.  Search results and tool selection in accordance with PRISMA guidelines  
 
Highlights 
 Numerous tools for gaming disorder (GD) have been developed in recent years. 
 We evaluated 32 GD tools and their evidence base from 320 empirical studies. 
 Several instruments had greater evidential support than others. 
 No single tool emerged as the clearly optimal choice. 
 A standard international tool would be invaluable to advance the GD field. 
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